BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21459950)

  • 1. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.
    Mak A; Liu Y; Ho RC
    J Rheumatol; 2011 Jul; 38(7):1296-303. PubMed ID: 21459950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
    Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
    Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC; Marder W; Kaplan MJ; Brook RD; McCune WJ
    Ann N Y Acad Sci; 2005 Jun; 1051():271-80. PubMed ID: 16126968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Stalc M; Tomsic M; Jezovnik MK; Poredos P
    Clin Exp Rheumatol; 2011; 29(4):616-23. PubMed ID: 21813059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.
    Mak A; Kow NY; Schwarz H; Gong L; Tay SH; Ling LH
    Sci Rep; 2017 Aug; 7(1):7320. PubMed ID: 28779080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
    Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT
    Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
    Tam LS; Fan B; Li EK; Thomas GN; Yim SF; Haines CJ; Tomlinson B
    J Rheumatol; 2003 Jul; 30(7):1479-84. PubMed ID: 12858444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachial endothelial function is impaired in patients with systemic lupus erythematosus.
    Lima DS; Sato EI; Lima VC; Miranda F; Hatta FH
    J Rheumatol; 2002 Feb; 29(2):292-7. PubMed ID: 11842823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?
    Witte DR; Westerink J; de Koning EJ; van der Graaf Y; Grobbee DE; Bots ML
    J Am Coll Cardiol; 2005 Jun; 45(12):1987-93. PubMed ID: 15963397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus.
    Aizer J; Karlson EW; Chibnik LB; Costenbader KH; Post D; Liang MH; Gall V; Gerhard-Herman MD
    Lupus; 2009 Mar; 18(3):235-42. PubMed ID: 19213862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.
    Mak A; Ling LH; Ho RC; Gong L; Cheak AA; Yee H; Vasoo S; Koh DR; Robless PA
    Clin Exp Rheumatol; 2011; 29(2):261-8. PubMed ID: 21385541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.